+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Amyloid beta -peptide-binding alcohol dehydrogenase is a component of the cellular response to nutritional stress

Amyloid beta -peptide-binding alcohol dehydrogenase is a component of the cellular response to nutritional stress

Journal of Biological Chemistry 275(35): 27100-9

Amyloid beta-peptide-binding alcohol dehydrogenase (ABAD) is a member of the family of short chain dehydrogenase/reductases whose distinctive properties include the capacity to bind amyloid beta-peptide and enzymatic activity toward a broad array of substrates including n-isopropanol and beta-estradiol. In view of the wide substrate specificity of ABAD and its high activity on l-beta-hydroxyacyl-CoA derivatives, we asked whether it might also catalyze the oxidation of the ketone body d-3-hydroxybutyrate. This was indeed the case, and oxidation proceeded with K(m) of approximately 4.5 mm and V(max) of approximately 4 nmol/min/mg protein. When placed in medium with d-beta-hydroxybutyrate as the principal energy substrate, COS cells stably transfected to overexpress wild-type ABAD (COS/wtABAD) better maintained 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide reduction, cellular energy charge, and morphologic phenotype compared with COS/vector cells. Using a severe model of metabolic perturbation, transgenic mice with targeted neuronal expression of ABAD subjected to transient middle cerebral artery occlusion showed strokes of smaller volume and lower neurologic deficit scores in parallel with increased brain ATP and decreased lactate, compared with nontransgenic controls. These data suggest that ABAD contributes to the protective response to metabolic stress, especially in the setting of ischemia.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 045217235

Download citation: RISBibTeXText

PMID: 10869339

DOI: 10.1074/jbc.M000055200

Related references

Amyloid b-peptide-binding alcohol dehydrogenase is a component of the cellular response to nutritional stress. The Journal of Biological Chemistry 275(35): 100-9, 2000

Cytoprotective role of mitochondrial amyloid beta peptide-binding alcohol dehydrogenase against a cytotoxic aldehyde. Neurobiology of Aging 30(2): 325-329, 2007

Cloning and expression of fusion gene of amyloid beta binding alcohol dehydrogenase decoy peptide aptamer (TRX1-ABAD-DP-TRX2). Zhonghua Yi Xue Za Zhi 92(1): 50-54, 2013

Ca(2+)-dependent binding of human serum amyloid P component to Alzheimer's beta-amyloid peptide. Journal of Biological Chemistry 270(18): 10392-4, 1995

Recognition of structurally diverse substrates by type II 3-hydroxyacyl-CoA dehydrogenase /amyloid-beta binding alcohol dehydrogenase. Journal of Molecular Biology 303(2): 311-327, 20 October, 2000

Recognition of structurally diverse substrates by type II 3-hydroxyacyl-CoA dehydrogenase (HADH II)/amyloid-beta binding alcohol dehydrogenase (ABAD). Journal of Molecular Biology 303(2): 311-327, 2000

Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease. Journal of Neuroscience 31(6): 2313-2320, 2011

Mitochondrial dysfunction and Alzheimer's disease: role of amyloid-beta peptide alcohol dehydrogenase (ABAD). International Journal of Experimental Pathology 86(3): 161-171, 2005

A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice. American Journal of Pathology 165(3): 937-948, 2004

Charge-based binding of complement component C1q to the Alzheimer amyloid beta-peptide. American Journal of Pathology 150(5): 1531-1536, 1997

Molecular dynamics simulations of the amyloid-beta binding alcohol dehydrogenase (ABAD) enzyme. Bioorganic and Medicinal Chemistry 16(21): 9511-9518, 2008

Cellular cofactors potentiating induction of stress and cytotoxicity by amyloid beta-peptide. Biochimica et Biophysica Acta 1502(1): 145-157, 2000

Ovariectomy increases neuronal amyloid-beta binding alcohol dehydrogenase level in the mouse hippocampus. Neurochemistry International 52(7): 1358-1364, 2008

Induction of cellular oxidative stress by the beta-amyloid peptide involved in Alzheimer's disease. Protein and Peptide Letters 11(3): 257-270, 2004

Amyloid-associated complement factor C1q and serum amyloid P-component enhance amyloid beta- and prion peptide-induced stimulatory effects on human microglia in vitro. Molecular Immunology 40(2-4): 187-188, September, 2003